Wu Sau-Ching, Yeung Jonathan C, Hwang Peter M, Wong Sui-Lam
Department of Biological Sciences, Division of Cellular, Molecular, and Microbial Biology, University of Calgary, 2500 University Drive, N.W., Calgary, Alberta T2N 1N4, Canada.
Protein Expr Purif. 2002 Apr;24(3):357-65. doi: 10.1006/prep.2001.1583.
A major attraction in using Bacillus subtilis as an expression host for heterologous protein production is its ability to secrete extracellular proteins into the culture medium. To take full advantage of this system, an efficient method for recovering the target protein is crucial. For secretory proteins which cannot be purified by a simple scheme, in vitro biotinylation using biotin ligase (BirA) offers an effective alternative for their purification. The availability of large amounts of quality BirA can be critical for in vitro biotinylation. We report here the engineering and production of an Escherichia coli BirA and its application in the purification of staphylokinase, a fibrin-specific plasminogen activator, from the culture supernatant of Bacillus subtilis via in vitro biotinylation. BirA was tagged with both a chitin-binding domain and a hexahistidine tail to facilitate both its purification and its removal from the biotinylated sample. We show in this paper how, in a unique way, we solved the problem of protein aggregation in the E. coli BirA production system to achieve a yield of soluble functional BirA hitherto unreported in the literature. Application of this novel BirA to protein purification via in vitro biotinylation in general will also be discussed. Biotinylated staphylokinase produced in the study not only can act as an intermediate for easy purification, it can also serve as an important element in the creation of a blood clot targeting and dissolving agent.
将枯草芽孢杆菌用作异源蛋白生产的表达宿主的一个主要吸引力在于其能够将细胞外蛋白分泌到培养基中。为了充分利用该系统,一种有效的回收目标蛋白的方法至关重要。对于无法通过简单方案纯化的分泌蛋白,使用生物素连接酶(BirA)进行体外生物素化提供了一种有效的纯化替代方法。大量优质BirA的可用性对于体外生物素化可能至关重要。我们在此报告了一种大肠杆菌BirA的工程改造和生产及其在通过体外生物素化从枯草芽孢杆菌培养上清液中纯化葡萄球菌激酶(一种纤维蛋白特异性纤溶酶原激活剂)中的应用。BirA同时标记有几丁质结合结构域和六聚组氨酸尾,以促进其纯化以及从生物素化样品中去除。我们在本文中展示了我们如何以独特的方式解决大肠杆菌BirA生产系统中的蛋白质聚集问题,以实现文献中迄今未报道的可溶性功能性BirA的产量。本文还将讨论这种新型BirA在一般体外生物素化蛋白质纯化中的应用。该研究中产生的生物素化葡萄球菌激酶不仅可以作为易于纯化的中间体,还可以作为创建靶向和溶解血凝块剂的重要元素。